BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20668229)

  • 1. The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.
    Green AS; Chapuis N; Maciel TT; Willems L; Lambert M; Arnoult C; Boyer O; Bardet V; Park S; Foretz M; Viollet B; Ifrah N; Dreyfus F; Hermine O; Moura IC; Lacombe C; Mayeux P; Bouscary D; Tamburini J
    Blood; 2010 Nov; 116(20):4262-73. PubMed ID: 20668229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia.
    Tamburini J; Green AS; Bardet V; Chapuis N; Park S; Willems L; Uzunov M; Ifrah N; Dreyfus F; Lacombe C; Mayeux P; Bouscary D
    Blood; 2009 Aug; 114(8):1618-27. PubMed ID: 19458359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileukemic activity of rapamycin in acute myeloid leukemia.
    Récher C; Beyne-Rauzy O; Demur C; Chicanne G; Dos Santos C; Mas VM; Benzaquen D; Laurent G; Huguet F; Payrastre B
    Blood; 2005 Mar; 105(6):2527-34. PubMed ID: 15550488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling.
    Kaur S; Lal L; Sassano A; Majchrzak-Kita B; Srikanth M; Baker DP; Petroulakis E; Hay N; Sonenberg N; Fish EN; Platanias LC
    J Biol Chem; 2007 Jan; 282(3):1757-68. PubMed ID: 17114181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
    Dowling RJ; Zakikhani M; Fantus IG; Pollak M; Sonenberg N
    Cancer Res; 2007 Nov; 67(22):10804-12. PubMed ID: 18006825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc Repression of TSC2 contributes to control of translation initiation and Myc-induced transformation.
    Ravitz MJ; Chen L; Lynch M; Schmidt EV
    Cancer Res; 2007 Dec; 67(23):11209-17. PubMed ID: 18056446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
    Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
    Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.
    Corradetti MN; Inoki K; Bardeesy N; DePinho RA; Guan KL
    Genes Dev; 2004 Jul; 18(13):1533-8. PubMed ID: 15231735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
    Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
    Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner.
    Miloslavski R; Cohen E; Avraham A; Iluz Y; Hayouka Z; Kasir J; Mudhasani R; Jones SN; Cybulski N; Rüegg MA; Larsson O; Gandin V; Rajakumar A; Topisirovic I; Meyuhas O
    J Mol Cell Biol; 2014 Jun; 6(3):255-66. PubMed ID: 24627160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.
    Huang X; Wullschleger S; Shpiro N; McGuire VA; Sakamoto K; Woods YL; McBurnie W; Fleming S; Alessi DR
    Biochem J; 2008 Jun; 412(2):211-21. PubMed ID: 18387000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia.
    Chapuis N; Tamburini J; Green AS; Vignon C; Bardet V; Neyret A; Pannetier M; Willems L; Park S; Macone A; Maira SM; Ifrah N; Dreyfus F; Herault O; Lacombe C; Mayeux P; Bouscary D
    Clin Cancer Res; 2010 Nov; 16(22):5424-35. PubMed ID: 20884625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
    Liu JL; Mao Z; Gallick GE; Yung WK
    Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells.
    Zhang C; Yang L; Geng YD; An FL; Xia YZ; Guo C; Luo JG; Zhang LY; Guo QL; Kong LY
    Oncotarget; 2016 May; 7(19):27819-37. PubMed ID: 27056897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.
    Tao YF; Li ZH; Du WW; Xu LX; Ren JL; Li XL; Fang F; Xie Y; Li M; Qian GH; Li YH; Li YP; Li G; Wu Y; Feng X; Wang J; He WQ; Hu SY; Lu J; Pan J
    Oncol Rep; 2017 Mar; 37(3):1419-1429. PubMed ID: 28184925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.
    Shi WY; Xiao D; Wang L; Dong LH; Yan ZX; Shen ZX; Chen SJ; Chen Y; Zhao WL
    Cell Death Dis; 2012 Mar; 3(3):e275. PubMed ID: 22378068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.
    Kimball SR; Siegfried BA; Jefferson LS
    J Biol Chem; 2004 Dec; 279(52):54103-9. PubMed ID: 15494402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression.
    Harada M; Benito J; Yamamoto S; Kaur S; Arslan D; Ramirez S; Jacamo R; Platanias L; Matsushita H; Fujimura T; Kazuno S; Kojima K; Tabe Y; Konopleva M
    Oncotarget; 2015 Nov; 6(35):37930-47. PubMed ID: 26473447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
    Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
    J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.